Prosetta Bioconformatics Private Limited (PBPL) is a Biotech/Biopharma company with current focus on developing anti-viral therapies and antibody engineering based on the path-breaking drug discovery platform developed by Prosetta Bioconformatics Inc, USA. PBPL was established in 2004 and started its independent research and development (R&D) operations in India from 2008. Our current operations are based out of our fully owned facility at Mysore, Karnataka, with state-of-the-art technology that caters to our research and commercial goals. Using its cutting edge research, PBPL is addressing issues central to drug discovery platform, antibody engineering, pre-clinical studies, monoclonal and polyclonal antibody generation and protein bioconformatics. Being a research and innovation driven company with a focus on translational research, PBPL works in close collaboration with academic institutes in India and other countries.

Our ultimate aim is to bridge the gap between fundamental scientific concepts and socially responsible commercialization.